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The roots of addiction are often attributed to the ability of repeated drug use to compromise proper
functioning of the central nervous system. Drug-induced functional changes in the brain occur on
many levels, including altered expression of specific genes via genomic and epigenetic mechanisms,
induction of synaptic plasticity and other cellular adaptations, and volumetric changes in discrete
brain regions (Luscher and Malenka, 2011). These alterations can be drug class-specific and occur
in both neuronal and non-neuronal cell populations. Drug-induced plasticity, or “rewiring” of the
brain contributes to the development, maintenance, and persistence of the addicted state (Kalivas
and O’Brien, 2008). The goal of this Research Topic is to assimilate recent findings related to
plasticity and structural alterations produced by drug of abuse in neurons, glia, and other cell types
of the brain.
The mesolimbic dopamine system, originating in the ventral tegmental area (VTA) of
the midbrain and projecting rostrally to the nucleus accumbens (NAc) and prefrontal cortex
(PFC), mediates the acute reinforcing and incentive salience of abused drugs, as well as their
aversive properties. As reviewed by Vashchinkina et al. (2014) mesolimbic dopamine neurons
are highly regulated by intrinsic and extrinsic inhibitory GABAergic neurons. Vashchinkina et al.
(2014) hypothesize that abused drugs induce structural and functional mesolimbic adaptations
differentially via endogenous (e.g., THIP and neurosteroids) vs. exogenous (e.g., benzodiazepines
and alcohol) modulators of GABAA receptors, as well as via synaptic vs. extrasynaptic GABAA
receptors in the VTA. Collo et al. (2014) review evidence that drug-induced plasticity inmesolimbic
dopaminergic neurons is mediated by common dopamine and brain-derived neurotrophic factor
(BDNF) signaling pathways, specifically those recruiting MEK-ERK1/2, and PI3K-Akt-mTOR.
Cadet and Bisagno (2014) review evidence for substantial plasticity in non-neuronal cell types in
brain reward circuitry, including changes in astrocytic glutamate transporter expression, increases
in pro-inflammatory cytokine production by microglia, and dysregulated oligodendrocytic myelin
production. This latter topic is further elaborated on by Somkuwar et al. (2014) in their review of
the proteoglycan neuron-glial antigen 2 (NG2), its expression by oligodendrocyte progenitor cells
in the brain reward circuitry, and its interaction with stress-related neuromodulators. In addition,
Bajo et al. (2015) provide evidence that interleukin-1β alters both basal and ethanol-facilitated
GABAergic transmission in the central nucleus of the amygdala, part of the extended amygdala
circuitry which is implicated in ethanol’s central effects.
Drugs of abuse also alter the dynamics and microstructure of both dendrites and
dendritic spines, which can be interpreted as cellular (mal)adaptations that reinforce
the addiction cycle (Luscher and Malenka, 2011; Gipson et al., 2014). DePoy et al.
(2014) show that repeated exposure of early adolescent mice to cocaine produces lasting
reductions in orbitofrontal cortex dendritic arbor length and complexity and as well
as impaired reversal learning. In addition, these investigators show that while mice
carrying a heterozygous deletion of the actin cytoskeleton stabilizing protein p190RhoGAP
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exhibit enhanced vulnerability to cocaine-induced
hyperlocomotion, orbitofrontal dendritic complexity in cocaine-
naïve mice is intact. These findings suggest that orbitofrontal
dendrite structure is impacted by repeated cocaine during
adolescence, but pre-existing structural dendritic deficiencies do
not account for increased behavioral sensitivity to this drug.
Glutamate is the predominant excitatory amino acid in
the central nervous system and mediates both normal and
maladaptive cellular plasticity. Several articles in this Research
Topic provide novel findings on the role of glutamate in addictive
processes. Weiland et al. (2015) demonstrate that antibiotics with
the glutamate and GABAmodulating properties (ceftriaxone and
cefazolin, respectively) attenuate cue-primed reinstatement of
alcohol-seeking. Griffin et al. (2015) demonstrate that chronic
intermittent ethanol exposure results in increased extracellular
levels of glutamate in the NAc in ethanol-dependent mice, but
these effects are not a result of locally dysregulated sodium-
dependent and independent glutamate transporter function,
suggesting that extrinsic corticostriatal glutamatergic pathways
may contribute to this hyperglutamatergic state. Finally,McGuier
et al. (2015) show that deletion of the excitatory postsynaptic
scaffolding protein Homer2 is associated with an increased
density of long, thin dendritic spines in NAc core medium spiny
neurons, yet unexpectedly these structural modifications are not
modified by repeated alcohol exposure.
Together, this body of work indicates complex interactions
between drugs of abuse, endogenous neuromodulators and
their signaling targets, and the mechanisms underlying the
functional and structural plasticity in the brain. Research into
this complexity is only in its infancy, and needs to be pursued at
multiple levels in order to better understand and treat addictive
disorders.
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